Pfizer Inc (NYSE:PFE) Big Money Sentiment Is 1.06

May 16, 2018 - By Nellie Deboer

Pfizer Inc. (NYSE:PFE) Corporate Logo

Pfizer Inc’s Sentiment

“Big money sentiment for Pfizer Inc (NYSE:PFE) in 2017 Q4 increased to 1.06, according to filings. That’s up 0.10, from 2017Q3’s 0.96. 766 investment professionals increased or started new positions, while 726 reduced and sold their positions in Pfizer Inc so the sentiment improved. These funds own 4.07 billion shares, that’s up from 4.06 billion shares in 2017Q3. Funds holding Pfizer Inc in top 10 changed to 112 from 139 for a decrease of 27. In total 51 funds closed positions, 675 reduced and 632 increased. Also 134 funds bought new Pfizer Inc stakes.

Biggest Pfizer Inc Investors

Northeast Financial Consultants Inc owns 1.33 million shares in Pfizer Inc as of 2017 Q4. Pfizer Inc’s shareholder Knott David M owns 933,276 shares as of 2017 Q4. Moreover, New England Professional Planning Group Inc. reported 233,894 shares in Pfizer Inc equivalent to 10.51% of its stocks portfolio. The New York-based fund Stuyvesant Capital Management have invested about 9.06% of the fund’s stock portfolio in Pfizer Inc. The Arkansas-based fund Foundation Resource Management Inc looks positive on Pfizer Inc, possessing 1.26 million shares.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide.The firm is worth $209.21 billion. It operates through two divisions, Pfizer Innovative Health and Pfizer Essential Health (EH).The P/E ratio is 9.94. The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as dietary supplements, pain management, gastrointestinal, and respiratory and personal care.

Ticker’s shares touched $35.765 during the last trading session after 0.21% change.Pfizer Inc. has volume of 6.89 million shares. Since May 16, 2017 PFE has risen 2.43% and is uptrending. PFE underperformed the S&P 500 by 9.12%.

On August, 7 is anticipated Pfizer Inc. (NYSE:PFE)’s earnings report, according to Zacks. Analysts have expectation on stock’s EPS of $0.75. That’s up 11.94 % from last year’s $0.67 EPS. PFE’s profit could hit $4.39B if the current EPS of $0.75 is accurate. After $0.77 EPS was announced last quarter, analysts now see negative EPS growth of -2.60 % for Pfizer Inc..

Loeb Prtn Corp holds 0.14% or 12,700 shs. Hanson & Doremus Invest Management reported 131,562 shs or 1.59% of all its holdings. Pittenger Anderson reported 0.26% of its capital in Pfizer Inc. (NYSE:PFE). Archon Ptnrs Ltd Liability Co reported 2.5% of its capital in Pfizer Inc. (NYSE:PFE). 1.85M are held by Hightower Advisors Lc. Girard Limited, a Pennsylvania-based fund reported 103,086 shs. Montag A holds 187,467 shs or 0.66% of its capital. 38,988 were reported by Peak Asset Management Lc. Naples Glob Advsr Limited Liability, a Florida-based fund reported 30,083 shs. Moreover, Hills Bank & Trust Com has 0.51% invested in Pfizer Inc. (NYSE:PFE) for 48,174 shs. Hedeker Wealth Ltd holds 2.05% or 72,820 shs. Thomas J Herzfeld Advsrs reported 0% of its capital in Pfizer Inc. (NYSE:PFE). Adage Cap Group Ltd Liability has invested 0.56% in Pfizer Inc. (NYSE:PFE). Wellington Shields And Comm Lc, a New York-based fund reported 53,739 shs. Orrstown Financial Serv invested in 1,425 shs or 0.06% of the stock.

Pfizer Inc. had 13 sales and 0 buys since December 15, 2017. This’s net activity of $17.75 million. JOHNSON RADY A also sold $296,560 worth of Pfizer Inc. (NYSE:PFE) shs. Dolsten Mikael sold 64,587 shs worth $2.39M. SUSMAN SALLY sold $1.24M worth of Pfizer Inc. (NYSE:PFE) on Monday, February 26. $249,750 worth of Pfizer Inc. (NYSE:PFE) was sold by MACKENZIE ALEXANDER R on Friday, December 15. READ IAN C sold $4.76 million worth of Pfizer Inc. (NYSE:PFE) on Tuesday, May 1. 26,779 shs were sold by HILL CHARLES H, worth $986,292 on Wednesday, February 28.

Pfizer Inc. (NYSE:PFE) Ratings Coverage

In total 9 analysts cover Pfizer (NYSE:PFE). “Buy” rating has 3, “Sell” are 1, while 5 are “Hold”. 33% are bullish. 14 are the (NYSE:PFE)’s analyst reports since November 21, 2017 according to StockzIntelligence Inc. On Wednesday, January 31 the stock has “Market Perform” rating by Leerink Swann. On Tuesday, January 16 the rating was maintained by Jefferies with “Hold”. The stock rating was maintained by Morgan Stanley with “Overweight” on Wednesday, January 31. On Sunday, January 28 the stock of Pfizer Inc. (NYSE:PFE) earned “Hold” rating by SunTrust. On Tuesday, November 21 the company was maintained by BMO Capital Markets. On Wednesday, January 31 the rating was maintained by Credit Suisse with “Neutral”. On Monday, February 26 the firm has “Hold” rating by Jefferies given. On Friday, December 15 the rating was maintained by BMO Capital Markets with “Buy”. In Thursday, April 5 report Barclays Capital downgraded the stock to “Equal-Weight” rating. On Wednesday, May 2 the stock of Pfizer Inc. (NYSE:PFE) earned “Outperform” rating by BMO Capital Markets.

For more Pfizer Inc. (NYSE:PFE) news released briefly go to:,,, or The titles are as follows: “What to Look For in the Merck and Pfizer Reports Tuesday Morning” released on April 30, 2018, “Pfizer (PFE) Announces FDA Approval for Biosimilar RETACRIT” on May 15, 2018, “Better Buy: Pfizer Inc. (PFE) vs. Merck (MRK)” with a publish date: May 13, 2018, “Pfizer Is A Definite Buy For 2018” and the last “Pfizer: Buy This Dip?” with publication date: May 03, 2018.

Pfizer Inc. (NYSE:PFE) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.